Survivors
In the clinical setting, determining the most effective path for breast cancer risk reduction requires a nuanced, data-driven…
Simone Boothe, 47, from Catford, can walk again following her incurable blood cancer diagnosis.
In this segment, the discussion shifts to a 70 year old patient with EGFR mutated metastatic non-small cell…
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
JNJ-1900, an investigational nanoparticle radioenhancer, represents a “fantastic opportunity” to improve the standard of care in stage III…
The teams debate whether CAR-T or bispecific antibodies should be prioritized as the treatment paradigm evolves in relapsed…